Jeffrey W Keillor

Jeffrey W Keillor

Ottawa University

H-index: 41

North America-United States

About Jeffrey W Keillor

Jeffrey W Keillor, With an exceptional h-index of 41 and a recent h-index of 22 (since 2020), a distinguished researcher at Ottawa University, specializes in the field of protein labelling, transglutaminase inhibitors.

His recent articles reflect a diverse array of research interests and contributions to the field:

Conformational Modulation of Tissue Transglutaminase via Active Site Thiol Alkylating Agents: Size Does Not Matter

Transcriptomics studies reveal functions of Transglutaminase 2 in breast cancer cells using membrane permeable and impermeable inhibitors

Fitting of kinact and KI Values from Endpoint Pre-incubation IC50 Data

Stabilizing transglutaminase 2 in the open conformation results in reactive astrocytes being more neurosupportive

Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines

High-Affinity Fluorogenic Substrate for Tissue Transglutaminase Reveals Enzymatic Hysteresis

Transglutaminase 2 binds to the CD44v6 cytoplasmic domain to stimulate CD44v6/ERK1/2 signaling and maintain an aggressive cancer phenotype

Cell-impermeable inhibitors confirm that intracellular human transglutaminase 2 is responsible for the transglutaminase-associated cancer phenotype

Jeffrey W Keillor Information

University

Position

Professor of Chemistry

Citations(all)

4443

Citations(since 2020)

1560

Cited By

3486

hIndex(all)

41

hIndex(since 2020)

22

i10Index(all)

92

i10Index(since 2020)

54

Email

University Profile Page

Google Scholar

Jeffrey W Keillor Skills & Research Interests

protein labelling

transglutaminase inhibitors

Top articles of Jeffrey W Keillor

Conformational Modulation of Tissue Transglutaminase via Active Site Thiol Alkylating Agents: Size Does Not Matter

Biomolecules

2024/4/19

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Transcriptomics studies reveal functions of Transglutaminase 2 in breast cancer cells using membrane permeable and impermeable inhibitors

Journal of Molecular Biology

2024/4/10

Fitting of kinact and KI Values from Endpoint Pre-incubation IC50 Data

ACS Medicinal Chemistry Letters

2024/4/4

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Stabilizing transglutaminase 2 in the open conformation results in reactive astrocytes being more neurosupportive

bioRxiv

2024

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines

The FEBS Journal

2023/11

High-Affinity Fluorogenic Substrate for Tissue Transglutaminase Reveals Enzymatic Hysteresis

Biochemistry

2023/10/19

Yasaman Heidari
Yasaman Heidari

H-Index: 4

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Transglutaminase 2 binds to the CD44v6 cytoplasmic domain to stimulate CD44v6/ERK1/2 signaling and maintain an aggressive cancer phenotype

Molecular Cancer Research

2023/9/1

Xi Chen
Xi Chen

H-Index: 13

Wen Xu
Wen Xu

H-Index: 8

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Cell-impermeable inhibitors confirm that intracellular human transglutaminase 2 is responsible for the transglutaminase-associated cancer phenotype

International Journal of Molecular Sciences

2023/8/8

Nicoletta Bianchi
Nicoletta Bianchi

H-Index: 25

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid

Cell Death & Disease

2023/6/13

Quinazoline-2-Carboxamides as Selective PET Radiotracers for Matrix Metalloproteinase-13 Imaging in Atherosclerosis

Journal of Medicinal Chemistry

2023/5/9

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

A kinetic study of thiol addition to N-phenylchloroacetamide

Organic & Biomolecular Chemistry

2023

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

A mechanistic study of thiol addition to N-acryloylpiperidine

Organic & Biomolecular Chemistry

2023

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase.

Molecules

2023/2/8

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Novel irreversible peptidic inhibitors of transglutaminase 2

RSC Medicinal Chemistry

2023

The war on hTG2: warhead optimization in small molecule human tissue transglutaminase inhibitors

RSC Medicinal Chemistry

2023

Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors

European Journal of Medicinal Chemistry

2022/3/15

Neda Firoozi
Neda Firoozi

H-Index: 5

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

A mechanistic study of thiol addition to N-phenylacrylamide

Organic & Biomolecular Chemistry

2022

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Structure–activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors

RSC Medicinal Chemistry

2022

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer

International Journal of Biological Sciences

2022

Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity

Molecular carcinogenesis

2022/1

Purushottamachar Puranik
Purushottamachar Puranik

H-Index: 12

Jeffrey W Keillor
Jeffrey W Keillor

H-Index: 22

See List of Professors in Jeffrey W Keillor University(Ottawa University)

Co-Authors

academic-engine